share_log

Reported Earlier, BrainStorm Cell Therapeutics Announces Management Changes As It Plans Registrational Phase 3b Trial Of NurOwn

Reported Earlier, BrainStorm Cell Therapeutics Announces Management Changes As It Plans Registrational Phase 3b Trial Of NurOwn

此前报道,BrainStorm Cell Therapeutics宣布管理层变动,计划对NuroWN进行3b期注册试验
Moomoo 24/7 ·  04/17 02:54
  • Bob Dagher, MD, Promoted to Chief Medical Officer
  • Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of Directors
  • 鲍勃·达格尔,医学博士,晋升为首席医疗官
  • Stacy Lindborg博士卸任联席首席执行官并过渡到董事会
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发